ARCA biopharma Inc

NASDAQ: ABIO    
Share price (5/1/24): $3.25    
Market cap (5/1/24): $47.1 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 96 pages Agreement and Plan of Merger and Reorganization Among: ARCA Biopharma, Inc.; Atlas Merger Sub Corp.; Atlas Merger Sub II, LLC; and Oruka Therapeutics, Inc. Dated as of April 3, 2024
12/34/56
EX-2
from SC 13D 18 pages Form of Warrant
12/34/56
EX-2.7
from S-4 10 pages Voting Agreement
12/34/56
EX-2.6
from S-4 10 pages Voting Agreement
12/34/56
EX-2.5
from 425 7 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.5
from 8-K 7 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.1
from 425 97 pages Agreement and Plan of Merger and Reorganization Among: Nuvelo, Inc., a Delaware Corporation; Dawn Acquisition Sub, Inc., a Delaware Corporation; and ARCA Biopharma, Inc., a Delaware Corporation Dated as of September 24, 2008
12/34/56
EX-2.1
from 8-K 97 pages Agreement and Plan of Merger and Reorganization Among: Nuvelo, Inc., a Delaware Corporation; Dawn Acquisition Sub, Inc., a Delaware Corporation; and ARCA Biopharma, Inc., a Delaware Corporation Dated as of September 24, 2008
12/34/56
EX-2.1
from 8-K 31 pages Stock Purchase Agreement Between Sbh Genomics, Inc., a Delaware Corporation, Radoje Drmanac, an Individual Snezana Drmanac, an Individual Nuvelo, Inc., a Delaware Corporation and Affymetrix, Inc., a Delaware Corporation Dated as of December 3, 2004
12/34/56
EX-2.1
from 8-K 5 pages Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K >50 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2
from 8-K 1 page Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2
from SC 13D ~10 pages Registration Rights Agreement
12/34/56